Drug Database
Back to search

United States· US:0220-0218_10e1b09c-a346-f74f-e063-6394a90a3b7c

Ambrosia artemisiaefolia

A medicinal product containing ambrosia artemisiifolia, registered in United States by Boiron.

US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedAmbrosia artemisiaefoliaATC—REGISTER NO.US:0220-0218_10e1b09c…PACKS LISTED2CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about ambrosia artemisiifoliaAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
AMBROSIA ARTEMISIIFOLIA
Manufacturer
Boiron
Country
United States (US)
ATC code
—
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 2

  • ndc11
    0220021841
    6 [hp_C] in 1 TUBE (0220-0218-41)
  • ndc11
    0220-0218-41

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Ambrosia artemisiifolia in 3 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All ambrosia artemisiifolia products

Authorised across Europe · EMA

The same active substance is authorised in 10 EEA countries. Names it is sold under:

  • Austria · Ragwizax
  • Bulgaria · Алиостал Прик, Алергенен Екстракт От Полени От Плевели, Рагвизакс
  • Czechia · Ragwizax
  • Germany · Alk-Prick N, Ambrosia (Ragweed) Hal Allergy
  • France · Ragwizax
  • Croatia · Ragwizax
  • Hungary · Alyostal Prick Pollenek, Lais Ragweed I
  • Romania · Ragwizax
  • Slovenia · Ragwizax
  • Slovakia · Ragwizax, Soluprick

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e5cab9bb-e61d-4d00-8dc0-944f5d0bf786
GET /v1/drugs/e5cab9bb-e61d-4d00-8dc0-944f5d0bf786?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "6",
  "substance": "AMBROSIA ARTEMISIIFOLIA",
  "productndc": "0220-0218",
  "dosage_form": "PELLET",
  "dea_schedule": null,
  "strength_unit": "[hp_C]/6[hp_C]",
  "application_number": null,
  "marketing_category": "UNAPPROVED HOMEOPATHIC"
}
API referenceMCP serverPlans

See everything about ambrosia artemisiifolia.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console